1,5-Anhydroglucitol: A Novel Biomarker of Adherence to Sodium-Glucose Cotransporter 2 Inhibitors

Diabetes Care. 2024 Feb 1;47(2):e9-e10. doi: 10.2337/dc23-2035.
No abstract available

MeSH terms

  • Biomarkers
  • Canagliflozin*
  • Deoxyglucose*
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucose
  • Humans
  • Hypoglycemic Agents
  • Sodium

Substances

  • 1,5-anhydroglucitol
  • Canagliflozin
  • Glucose
  • Biomarkers
  • Sodium
  • Hypoglycemic Agents
  • Deoxyglucose